Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

Neutropenia is a common side effect associated with nab-paclitaxel gemcitabine (Nab-Gem) therapy. We retrospectively investigated the association between neutropenia induced by first-line Nab-Gem and survival in metastatic pancreatic carcinoma patients. Metastatic pancreatic patients treated with fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Roviello, Giandomenico, Ramello, Monica, Catalano, Martina, D’Angelo, Alberto, Conca, Raffaele, Gasperoni, Silvia, Dreoni, Lorenzo, Petrioli, Roberto, Ianza, Anna, Nobili, Stefania, Aieta, Michele, Mini, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648798/
https://www.ncbi.nlm.nih.gov/pubmed/33159172
http://dx.doi.org/10.1038/s41598-020-76465-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648798/
https://www.ncbi.nlm.nih.gov/pubmed/33159172
http://dx.doi.org/10.1038/s41598-020-76465-9

Ejemplares similares